[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-001", "question": "A 16-year-old female presents with episodes of muscle weakness and palpitations. Physical exam reveals low-set ears, micrognathia, and clinodactyly. ECG demonstrates frequent PVCs, a QTc of 490 ms, and prominent U waves. Genetic testing confirms a loss-of-function mutation in KCNJ2. She continues to have frequent non-sustained ventricular tachycardia despite beta-blocker therapy. What is the most appropriate pharmacologic management for her arrhythmia?", "options": ["Option A: Nadolol", "Option B: Amiodarone", "Option C: Flecainide", "Option D: Mexiletine", "Option E: Verapamil"], "answer": "C", "answer_index": 2, "explanation": "This patient has Andersen-Tawil Syndrome (LQT7), characterized by the triad of periodic paralysis, dysmorphic features, and QT/U wave abnormalities. Unlike other Long QT Syndromes where sodium channel blockers are often contraindicated, Flecainide is uniquely effective in suppressing the ventricular arrhythmias associated with KCNJ2 mutations.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The item describes a classic presentation of Andersen-Tawil Syndrome (LQT7), characterized by the triad of periodic paralysis (muscle weakness), dysmorphic features, and ventricular arrhythmias with prominent U waves, confirmed by the KCNJ2 mutation. The clinical scenario specifies that the patient has recurrent arrhythmias despite beta-blocker therapy. In this specific subtype of Long QT Syndrome, Flecainide is the established, unique pharmacologic intervention of choice for suppressing ventricular arrhythmias, distinguishing it from other LQT subtypes where sodium channel blockers might be contraindicated or less effective. Mexiletine is typically reserved for LQT3, and Amiodarone is generally avoided in LQTS due to QT prolongation risks. The stem provides all necessary details to diagnose the condition and identify the specific management step required. The key (C) is the medically correct best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The item describes a classic presentation of Andersen-Tawil Syndrome (LQT7), characterized by the triad of periodic paralysis (muscle weakness), dysmorphic features, and ventricular arrhythmias with prominent U waves, confirmed by the KCNJ2 mutation. The clinical scenario specifies that the patient has recurrent arrhythmias despite beta-blocker therapy. In this specific subtype of Long QT Syndrome, Flecainide is the established, unique pharmacologic intervention of choice for suppressing ventricular arrhythmias, distinguishing it from other LQT subtypes where sodium channel blockers might be contraindicated or less effective. Mexiletine is typically reserved for LQT3, and Amiodarone is generally avoided in LQTS due to QT prolongation risks. The stem provides all necessary details to diagnose the condition and identify the specific management step required. The key (C) is the medically correct best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-002", "question": "A 55-year-old man presents with bone pain and exophthalmos. CT imaging reveals perinephric infiltration with a 'hairy kidney' appearance and osteosclerotic lesions in the distal femur. Biopsy of the retroperitoneal tissue shows infiltration by foamy histiocytes that are CD68+ and CD1a-. Molecular testing reveals a BRAF V600E mutation. Which therapeutic agent is most indicated?", "options": ["Option A: Rituximab", "Option B: High-dose Prednisone", "Option C: Vemurafenib", "Option D: Methotrexate", "Option E: Infliximab"], "answer": "C", "answer_index": 2, "explanation": "The clinical presentation (hairy kidney, osteosclerosis, exophthalmos) and pathology (CD68+, CD1a- foamy histiocytes) are diagnostic of Erdheim-Chester Disease (ECD), a non-Langerhans cell histiocytosis. Over 50% of cases carry the BRAF V600E mutation. Targeted therapy with a BRAF inhibitor (Vemurafenib) is the treatment of choice for BRAF-positive ECD, superior to empiric immunosuppression.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer.\\nThe vignette presents a textbook case of Erdheim-Chester Disease (ECD), characterized by the pathognomonic \\\"hairy kidney\\\" (perinephric fibrosis), osteosclerotic bone lesions, and exophthalmos. The immunophenotype (CD68+, CD1a-) confirms a non-Langerhans cell histiocytosis, distinguishing it from Langerhans Cell Histiocytosis (LCH). Crucially, the patient is BRAF V600E positive.\\n\\nCurrent consensus and FDA approvals designate BRAF inhibitors (e.g., Vemurafenib) as the first-line treatment for BRAF-mutated ECD, offering significantly higher response rates than conventional chemotherapy or immunotherapy. Option B (Prednisone) and interferon-alpha (not listed) were historical treatments but are now considered inferior to targeted therapy in mutated cases. Option A (Rituximab) is appropriate for IgG4-related disease (a differential diagnosis), but the specific mutation and histology rule this out. The item is logically sound, medically accurate, and relies on specific molecular data to drive the unique best answer. No changes are required.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer.\nThe vignette presents a textbook case of Erdheim-Chester Disease (ECD), characterized by the pathognomonic \"hairy kidney\" (perinephric fibrosis), osteosclerotic bone lesions, and exophthalmos. The immunophenotype (CD68+, CD1a-) confirms a non-Langerhans cell histiocytosis, distinguishing it from Langerhans Cell Histiocytosis (LCH). Crucially, the patient is BRAF V600E positive.\n\nCurrent consensus and FDA approvals designate BRAF inhibitors (e.g., Vemurafenib) as the first-line treatment for BRAF-mutated ECD, offering significantly higher response rates than conventional chemotherapy or immunotherapy. Option B (Prednisone) and interferon-alpha (not listed) were historical treatments but are now considered inferior to targeted therapy in mutated cases. Option A (Rituximab) is appropriate for IgG4-related disease (a differential diagnosis), but the specific mutation and histology rule this out. The item is logically sound, medically accurate, and relies on specific molecular data to drive the unique best answer. No changes are required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-003", "question": "A 32-year-old G1P0 woman at 35 weeks gestation presents with nausea, vomiting, and jaundice. Labs show AST 300 U/L, ALT 350 U/L, Platelets 80,000/mm3, Glucose 45 mg/dL, and INR 2.5. A diagnosis of Acute Fatty Liver of Pregnancy (AFLP) is made, and the infant is delivered urgently. To prevent sudden death in the neonate, which specific screening test should be prioritized?", "options": ["Option A: Serum ammonia and lactate", "Option B: Plasma acylcarnitine profile", "Option C: Galactose-1-phosphate uridyltransferase", "Option D: Very long-chain fatty acids (VLCFA)", "Option E: Hemoglobin electrophoresis"], "answer": "B", "answer_index": 1, "explanation": "Maternal AFLP is strongly associated with fetal Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Fetal fatty acid oxidation defects cause accumulation of metabolites that cross the placenta and overwhelm the maternal liver. The neonate is at high risk for hypoketotic hypoglycemia and sudden death; an acylcarnitine profile is diagnostic.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict on keyed answer: Correct best.\\n\\nThe vignette describes a classic presentation of Acute Fatty Liver of Pregnancy (AFLP), characterized by third-trimester liver failure, hypoglycemia, and coagulopathy. There is a strong, well-documented association between maternal AFLP and fetal Fatty Acid Oxidation Disorders (FAODs), specifically Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. The fetus is unable to process fatty acids, leading to metabolite accumulation that stresses the heterozygous maternal liver. The neonate is at high risk for hypoketotic hypoglycemia, liver failure, and sudden death.\\n\\nOption B (Plasma acylcarnitine profile) is the correct specific screening test to identify LCHAD deficiency and other FAODs. Option A (Ammonia/Lactate) is non-specific for the etiology. Options C (Galactosemia), D (Peroxisomal disorders), and E (Hemoglobinopathies) screen for conditions unrelated to the specific maternal-fetal pathophysiology described. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best.\n\nThe vignette describes a classic presentation of Acute Fatty Liver of Pregnancy (AFLP), characterized by third-trimester liver failure, hypoglycemia, and coagulopathy. There is a strong, well-documented association between maternal AFLP and fetal Fatty Acid Oxidation Disorders (FAODs), specifically Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. The fetus is unable to process fatty acids, leading to metabolite accumulation that stresses the heterozygous maternal liver. The neonate is at high risk for hypoketotic hypoglycemia, liver failure, and sudden death.\n\nOption B (Plasma acylcarnitine profile) is the correct specific screening test to identify LCHAD deficiency and other FAODs. Option A (Ammonia/Lactate) is non-specific for the etiology. Options C (Galactosemia), D (Peroxisomal disorders), and E (Hemoglobinopathies) screen for conditions unrelated to the specific maternal-fetal pathophysiology described. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-004", "question": "A 24-year-old male with HIV and known G6PD deficiency develops cyanosis and dyspnea after receiving dapsone. SpO2 is 85% and arterial blood is chocolate-colored. Methemoglobin level is 25%. He is inadvertently treated with methylene blue, after which his condition deteriorates with evidence of acute hemolysis and worsening hypoxia. What is the most appropriate next step in management?", "options": ["Option A: Repeat Methylene Blue dose", "Option B: High-dose Ascorbic Acid (Vitamin C)", "Option C: Exchange transfusion", "Option D: Hyperbaric oxygen therapy", "Option E: Hydroxocobalamin"], "answer": "C", "answer_index": 2, "explanation": "Methylene blue requires NADPH (generated via the G6PD pathway) to reduce methemoglobin. In G6PD deficiency, it is ineffective and can induce severe hemolysis (as seen here). Ascorbic acid is too slow for acute severe toxicity. Exchange transfusion is the definitive rescue therapy to rapidly remove the methemoglobin and the offending agent.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette presents a classic board-exam scenario: acquired methemoglobinemia (induced by dapsone) in a patient with G6PD deficiency, erroneously treated with methylene blue. Methylene blue requires NADPH (generated via G6PD) to function; in G6PD-deficient patients, it is ineffective and induces oxidative hemolysis, explaining the patient's deterioration. The question asks for the next step in management given this failure and complication. Exchange transfusion (Option C) is the standard of care for severe methemoglobinemia in G6PD-deficient patients or when methylene blue is ineffective/contraindicated, as it rapidly removes both the methemoglobin and the offending agent. Option A is contraindicated. Option B (Ascorbic acid) is widely regarded as too slow for acute, severe symptomatic cases. Option D (Hyperbaric oxygen) allows for tissue oxygenation but does not remove the methemoglobin or stop hemolysis as effectively as exchange transfusion in this specific context. The item is medically accurate, logically sound, and possesses a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette presents a classic board-exam scenario: acquired methemoglobinemia (induced by dapsone) in a patient with G6PD deficiency, erroneously treated with methylene blue. Methylene blue requires NADPH (generated via G6PD) to function; in G6PD-deficient patients, it is ineffective and induces oxidative hemolysis, explaining the patient's deterioration. The question asks for the next step in management given this failure and complication. Exchange transfusion (Option C) is the standard of care for severe methemoglobinemia in G6PD-deficient patients or when methylene blue is ineffective/contraindicated, as it rapidly removes both the methemoglobin and the offending agent. Option A is contraindicated. Option B (Ascorbic acid) is widely regarded as too slow for acute, severe symptomatic cases. Option D (Hyperbaric oxygen) allows for tissue oxygenation but does not remove the methemoglobin or stop hemolysis as effectively as exchange transfusion in this specific context. The item is medically accurate, logically sound, and possesses a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-005", "question": "A 3-month-old male presents with generalized erythroderma, lymphadenopathy, hepatosplenomegaly, and chronic diarrhea. CBC reveals eosinophilia and lymphocytosis. Immunophenotyping shows an absence of B cells, but elevated numbers of oligoclonal, activated T cells. Which genetic defect is most consistent with this presentation?", "options": ["Option A: BTK mutation", "Option B: Hypomorphic RAG1/RAG2 mutation", "Option C: CD40 Ligand mutation", "Option D: STAT3 mutation", "Option E: WAS gene mutation"], "answer": "B", "answer_index": 1, "explanation": "This is Omenn Syndrome, a form of 'leaky' Severe Combined Immunodeficiency (SCID). It is caused by hypomorphic mutations in RAG1 or RAG2 that allow for partial V(D)J recombination. This results in the absence of B cells but the development of a restricted, autoreactive T-cell repertoire that infiltrates tissues (erythroderma, hepatosplenomegaly) and causes high IgE/eosinophilia.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic presentation of Omenn syndrome: an infant with generalized erythroderma, lymphadenopathy, hepatosplenomegaly, chronic diarrhea, and eosinophilia. The specific immunophenotype—absent B cells combined with elevated, oligoclonal, activated T cells—is pathognomonic for this condition. Omenn syndrome is a form of 'leaky' Severe Combined Immunodeficiency (SCID) caused by partial V(D)J recombination activity. This is most characteristically associated with hypomorphic mutations in RAG1 or RAG2 (Option B). Option A (BTK) causes X-linked agammaglobulinemia, characterized by absent B cells but normal T cells and no erythroderma. Option C (CD40L) causes Hyper-IgM syndrome, which does not present with this specific lymphocyte subset profile. Option D (STAT3) causes Hyper-IgE syndrome (Job syndrome), characterized by cold abscesses, coarse facies, and eczema, but not the SCID-like features or oligoclonal T cells seen here. Option E (WAS) is associated with microthrombocytopenia and eczema, distinct from the findings in the stem. The question is medically accurate, logically sound, and points to a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic presentation of Omenn syndrome: an infant with generalized erythroderma, lymphadenopathy, hepatosplenomegaly, chronic diarrhea, and eosinophilia. The specific immunophenotype—absent B cells combined with elevated, oligoclonal, activated T cells—is pathognomonic for this condition. Omenn syndrome is a form of 'leaky' Severe Combined Immunodeficiency (SCID) caused by partial V(D)J recombination activity. This is most characteristically associated with hypomorphic mutations in RAG1 or RAG2 (Option B). Option A (BTK) causes X-linked agammaglobulinemia, characterized by absent B cells but normal T cells and no erythroderma. Option C (CD40L) causes Hyper-IgM syndrome, which does not present with this specific lymphocyte subset profile. Option D (STAT3) causes Hyper-IgE syndrome (Job syndrome), characterized by cold abscesses, coarse facies, and eczema, but not the SCID-like features or oligoclonal T cells seen here. Option E (WAS) is associated with microthrombocytopenia and eczema, distinct from the findings in the stem. The question is medically accurate, logically sound, and points to a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-006", "question": "A 4-month-old infant presents with failure to thrive and diaphoresis during feeding. ECG reveals deep Q waves in leads I, aVL, and V5-V6. Echocardiography demonstrates a dilated left ventricle. During color Doppler interrogation of the coronary arteries, which flow pattern confirms the diagnosis of Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA)?", "options": ["Option A: Diastolic flow from the aorta into the left coronary artery", "Option B: Systolic flow from the pulmonary artery into the left coronary artery", "Option C: Retrograde flow from the left coronary artery into the pulmonary artery", "Option D: Continuous flow from the aorta to the pulmonary artery", "Option E: Turbulent high-velocity flow at the left coronary ostium"], "answer": "C", "answer_index": 2, "explanation": "In the infant/adult type of ALCAPA, pulmonary vascular resistance drops, causing flow reversal. Blood flows from the aorta to the Right Coronary Artery, through collaterals to the Left Coronary Artery, and then retrograde into the low-pressure Pulmonary Artery (coronary steal). The hallmark is retrograde flow into the PA.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The vignette describes a classic presentation of Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA) in a 4-month-old infant (failure to thrive, diaphoresis/angina with feeding, lateral Q waves, dilated LV). The question asks for the confirmatory Doppler flow pattern. By 4 months of age, pulmonary vascular resistance (PVR) has dropped below systemic pressure. This pressure gradient causes blood to flow from the high-pressure aorta into the Right Coronary Artery, through collaterals to the Left Coronary Artery, and then retrograde into the low-pressure Pulmonary Artery (coronary steal). Therefore, the diagnostic hallmark on color Doppler is retrograde flow from the LCA into the PA. Option C correctly describes this physiology. Option A describes normal anatomy. Option B describes the neonatal phase (high PVR) or is incorrect for the symptomatic ischemic phase. Option D describes a PDA. The item is medically accurate and supports a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The vignette describes a classic presentation of Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA) in a 4-month-old infant (failure to thrive, diaphoresis/angina with feeding, lateral Q waves, dilated LV). The question asks for the confirmatory Doppler flow pattern. By 4 months of age, pulmonary vascular resistance (PVR) has dropped below systemic pressure. This pressure gradient causes blood to flow from the high-pressure aorta into the Right Coronary Artery, through collaterals to the Left Coronary Artery, and then retrograde into the low-pressure Pulmonary Artery (coronary steal). Therefore, the diagnostic hallmark on color Doppler is retrograde flow from the LCA into the PA. Option C correctly describes this physiology. Option A describes normal anatomy. Option B describes the neonatal phase (high PVR) or is incorrect for the symptomatic ischemic phase. Option D describes a PDA. The item is medically accurate and supports a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-007", "question": "A 60-year-old male presents with nephrotic syndrome. Labs show low serum C3 and normal C4. Kidney biopsy reveals C3-dominant staining on immunofluorescence and a membranoproliferative pattern on light microscopy. Serum protein electrophoresis is negative, but serum free light chain assay shows a kappa:lambda ratio of 5.0. What is the most appropriate treatment to preserve renal function?", "options": ["Option A: Eculizumab", "Option B: Mycophenolate Mofetil", "Option C: Clone-directed chemotherapy (e.g., Bortezomib-based)", "Option D: High-dose steroids alone", "Option E: Plasma exchange"], "answer": "C", "answer_index": 2, "explanation": "This patient has C3 Glomerulopathy (C3G) secondary to a Monoclonal Gammopathy of Renal Significance (MGRS). The monoclonal protein acts as an autoantibody (e.g., C3 nephritic factor) driving complement activation. The standard of care is to treat the underlying clone (plasma cell directed therapy) rather than non-specific immunosuppression or complement inhibition alone.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient with C3 Glomerulopathy (C3G), evidenced by low C3, normal C4, and C3-dominant biopsy. The critical discriminator is the abnormal kappa:lambda free light chain ratio of 5.0, which indicates a monoclonal gammopathy despite the negative SPEP. This clinical picture represents Monoclonal Gammopathy of Renal Significance (MGRS). In MGRS-associated C3G, the monoclonal protein drives complement activation. Current consensus guidelines (e.g., IKMG) recommend clone-directed therapy (Option C) as the definitive treatment to preserve renal function by eliminating the pathogenic clone. Eculizumab (Option A) and MMF (Option B) are used in idiopathic C3G but are inferior to clone-directed therapy when a monoclonal trigger is identified. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient with C3 Glomerulopathy (C3G), evidenced by low C3, normal C4, and C3-dominant biopsy. The critical discriminator is the abnormal kappa:lambda free light chain ratio of 5.0, which indicates a monoclonal gammopathy despite the negative SPEP. This clinical picture represents Monoclonal Gammopathy of Renal Significance (MGRS). In MGRS-associated C3G, the monoclonal protein drives complement activation. Current consensus guidelines (e.g., IKMG) recommend clone-directed therapy (Option C) as the definitive treatment to preserve renal function by eliminating the pathogenic clone. Eculizumab (Option A) and MMF (Option B) are used in idiopathic C3G but are inferior to clone-directed therapy when a monoclonal trigger is identified. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-008", "question": "A patient with severe ARDS is ventilated in Assist-Control Volume Control mode. He is deeply sedated but not paralyzed. Ventilator graphics display a time-triggered mandatory breath, followed immediately by a drop in esophageal pressure (diaphragmatic contraction) occurring during the inspiratory phase, which triggers a second breath during exhalation (breath stacking). This phenomenon is best described as:", "options": ["Option A: Double triggering due to flow starvation", "Option B: Reverse triggering", "Option C: Ineffective triggering", "Option D: Premature cycling", "Option E: Auto-triggering"], "answer": "B", "answer_index": 1, "explanation": "Reverse triggering is a form of patient-ventilator dyssynchrony where the passive insufflation from the ventilator mechanically stretches the diaphragm, reflexively inducing a patient respiratory effort (entrainment). If this induced effort is strong enough, it can trigger a second breath (breath stacking). It is distinct from double triggering caused by high patient drive.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a specific form of patient-ventilator dyssynchrony where a mandatory (time-triggered) ventilator breath mechanically stretches the diaphragm, reflexively inducing a patient respiratory effort (drop in esophageal pressure) during the inspiratory phase. This induced effort then triggers a second breath (breath stacking). This sequence—machine breath causing patient effort—is the definition of Reverse Triggering (Option B). Option A (Double triggering due to flow starvation) is incorrect because flow starvation typically involves a patient-initiated breath where the patient's demand exceeds delivery, leading to a second effort; here, the breath is machine-initiated and the patient is deeply sedated. Option C is incorrect because the effort *did* trigger a breath. Option E is incorrect because the trigger is due to a real diaphragmatic contraction, not an artifact. The item is medically accurate, the description is precise, and the distractors are distinct entities.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a specific form of patient-ventilator dyssynchrony where a mandatory (time-triggered) ventilator breath mechanically stretches the diaphragm, reflexively inducing a patient respiratory effort (drop in esophageal pressure) during the inspiratory phase. This induced effort then triggers a second breath (breath stacking). This sequence—machine breath causing patient effort—is the definition of Reverse Triggering (Option B). Option A (Double triggering due to flow starvation) is incorrect because flow starvation typically involves a patient-initiated breath where the patient's demand exceeds delivery, leading to a second effort; here, the breath is machine-initiated and the patient is deeply sedated. Option C is incorrect because the effort *did* trigger a breath. Option E is incorrect because the trigger is due to a real diaphragmatic contraction, not an artifact. The item is medically accurate, the description is precise, and the distractors are distinct entities.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-009", "question": "A 28-year-old G2P2 woman presents 3 months postpartum with extensive ecchymoses and bleeding from a minor cut. Coagulation studies show aPTT 78s and PT 12s. A mixing study fails to correct the aPTT. Factor VIII activity is <1%. Which agent is the most appropriate first-line therapy for acute bleeding control?", "options": ["Option A: Desmopressin (DDAVP)", "Option B: Cryoprecipitate", "Option C: Recombinant Human Factor VIII", "Option D: Recombinant Porcine Factor VIII", "Option E: High-dose Prednisone"], "answer": "D", "answer_index": 3, "explanation": "This is acquired hemophilia A (postpartum), caused by an inhibitor (autoantibody) to Factor VIII. Human Factor VIII (and Cryoprecipitate) will be neutralized by the inhibitor and is ineffective. First-line hemostatic agents are bypassing agents (rFVIIa or FEIBA) or Recombinant Porcine Factor VIII (which has low cross-reactivity with human anti-FVIII antibodies). Prednisone treats the clone but does not stop acute bleeding.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette describes a classic case of Acquired Hemophilia A (AHA) in a postpartum woman: isolated prolonged aPTT, failure to correct on mixing study (indicating an inhibitor), and severe Factor VIII deficiency. The question specifically asks for 'acute bleeding control.' In AHA, autoantibodies against human Factor VIII render human FVIII products (Option C) and Cryoprecipitate (Option B) ineffective. Desmopressin (Option A) is ineffective for severe deficiency/inhibitors. High-dose Prednisone (Option E) is the standard of care for *inhibitor eradication* but does not provide immediate hemostasis. Recombinant Porcine Factor VIII (Option D) is a first-line hemostatic agent for AHA because human anti-FVIII antibodies typically have low cross-reactivity with porcine FVIII, allowing it to restore hemostasis. The item correctly distinguishes between hemostatic therapy and immunosuppressive therapy, a common board-exam concept.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette describes a classic case of Acquired Hemophilia A (AHA) in a postpartum woman: isolated prolonged aPTT, failure to correct on mixing study (indicating an inhibitor), and severe Factor VIII deficiency. The question specifically asks for 'acute bleeding control.' In AHA, autoantibodies against human Factor VIII render human FVIII products (Option C) and Cryoprecipitate (Option B) ineffective. Desmopressin (Option A) is ineffective for severe deficiency/inhibitors. High-dose Prednisone (Option E) is the standard of care for *inhibitor eradication* but does not provide immediate hemostasis. Recombinant Porcine Factor VIII (Option D) is a first-line hemostatic agent for AHA because human anti-FVIII antibodies typically have low cross-reactivity with porcine FVIII, allowing it to restore hemostasis. The item correctly distinguishes between hemostatic therapy and immunosuppressive therapy, a common board-exam concept.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-010", "question": "A traveler returns from Malaysian Borneo with daily high-grade fevers and severe thrombocytopenia. Blood smear reveals high parasitemia with 'band form' trophozoites resembling Plasmodium malariae, but the clinical severity mimics Plasmodium falciparum. Which feature distinguishes the replication cycle of this pathogen from P. falciparum?", "options": ["Option A: 24-hour erythrocytic cycle", "Option B: 48-hour erythrocytic cycle", "Option C: 72-hour erythrocytic cycle", "Option D: Presence of a hypnozoite stage", "Option E: Preferential invasion of reticulocytes"], "answer": "A", "answer_index": 0, "explanation": "The pathogen is Plasmodium knowlesi, a zoonotic malaria. A key feature driving its potential for hyperparasitemia and severe disease is its unique 24-hour (quotidian) erythrocytic replication cycle. P. falciparum has a 48-hour cycle, and P. malariae has a 72-hour cycle. P. knowlesi does not have a hypnozoite stage (unlike P. vivax/ovale).", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe vignette provides a classic description of Plasmodium knowlesi infection: travel to Malaysian Borneo, daily (quotidian) fevers, severe thrombocytopenia, high parasitemia, and morphology resembling P. malariae (band forms). The question asks for a feature of this pathogen (P. knowlesi) that distinguishes its replication cycle from P. falciparum. P. knowlesi is unique among human-infecting Plasmodium species for having a 24-hour erythrocytic cycle, which drives its rapid replication and potential for severe disease. P. falciparum has a 48-hour cycle (tertian), and P. malariae has a 72-hour cycle (quartan). Neither P. knowlesi nor P. falciparum has a hypnozoite stage (Option D). Therefore, Option A is the scientifically correct and unique best answer. The item is logically sound and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe vignette provides a classic description of Plasmodium knowlesi infection: travel to Malaysian Borneo, daily (quotidian) fevers, severe thrombocytopenia, high parasitemia, and morphology resembling P. malariae (band forms). The question asks for a feature of this pathogen (P. knowlesi) that distinguishes its replication cycle from P. falciparum. P. knowlesi is unique among human-infecting Plasmodium species for having a 24-hour erythrocytic cycle, which drives its rapid replication and potential for severe disease. P. falciparum has a 48-hour cycle (tertian), and P. malariae has a 72-hour cycle (quartan). Neither P. knowlesi nor P. falciparum has a hypnozoite stage (Option D). Therefore, Option A is the scientifically correct and unique best answer. The item is logically sound and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]